🔎 Trials Near Me

Início › Doenças Pulmonares Intersticiais › Pensilvânia

Ensaios clínicos de Doenças Pulmonares Intersticiais em Pensilvânia

18 estudos para Doenças Pulmonares Intersticiais estão buscando participantes em locais em Pensilvânia.

Cidades em Pensilvânia

Texto oficial do estudo (Inglês)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University of Pennsylvania, Philadelphia
  • Temple University, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • University of Pennsylvania, Philadelphia
RecrutandoFase 3
Idades 40 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA013, Philadelphia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Thomas Jefferson University, Philadelphia
  • Temple Lung Center, Temple University, Philadelphia
  • UPMC Montefiore, Pittsburgh
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05798923

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06716606

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Philadelphia
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Philadelphia
  • GSK Investigational Site, Pittsburgh
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Thomas Jefferson University, Philadelphia
  • Temple University of The Commonwealth System of Higher Education, Philadelphia
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06911632

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

  • Michelle F MacPherson, Pittsburgh
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT00258583

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • St. Luke's University Health Network, Bethlehem
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
  • e mais 2
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06195072

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
  • University of Pittsburgh Medical Center, Pittsburgh
RecrutandoFase 2
Idades de 8 a 60 · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT03630211

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Temple University, Philadelphia
  • Thomas Jefferson University, Philadelphia
RecrutandoEstudo observacional
Idades 21 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Temple University, Philadelphia
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Pennsylvania State Hershey Medical Center and College of Medicine, Hershey
  • Hospital of the University of Pennsylvania, Philadelphia
  • Jefferson Honickman Center, Philadelphia
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

  • Children's Hospital of Philadelphia, Philadelphia
RecrutandoEstudo observacional
Até 24 anos · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT04098445

Feasibility of Semaglutide in Advanced Lung Disease

  • University of Pennsylvania Perelman School of Medicine, Philadelphia
RecrutandoFase 1/2
Idades de 18 a 80 · Todos os sexos · Atualizado em 21 de abr. de 2026 · NCT05746039

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Temple University Hospital-Temple Lung Center, Philadelphia
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 12 de nov. de 2025 · NCT05975983

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.